[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567365":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":12,"responsibleParty":32,"collaborators":10,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":38,"acronym":10,"eligibilityCriteria":39,"healthyVolunteers":36,"sex":40,"minAge":41,"maxAge":10,"enrollmentInfo":42,"targetDuration":10,"studyType":45,"phases":10,"briefSummary":46,"conditions":47,"keywords":10,"overallStatus":51,"whyStopped":10,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":61},{"fullName":5,"class":6},"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients > 18 years old who are going to be immunized against HZ",null,"Patients \\> 18 years old who are going to be immunized against HZ",[13],{"facility":14,"status":10,"city":15,"state":10,"zip":16,"country":17,"countryCode":18,"cosmosGeoPoint":19,"geoPoint":24,"contacts":25},"Hospital Universitario Fundación Jiménez Díaz","Madrid","28040","Spain","ES",{"type":20,"coordinates":21},"Point",[22,23],-3.70256,40.4165,{"lat":23,"lon":22},[26],{"name":27,"role":28,"phone":29,"phoneExt":30,"email":31},"ALBA VEGA, PhD investigator","CONTACT","915504800","4787","alba.vegav@quironsalud.es",{"type":33,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100567365","impact-on-quality-of-life-and-burden-of-disease-in-adults-with-herpes-zoster-100567365",false,"NCT06667245","Impact on Quality of Life and Burden of Disease in Adults With Herpes Zoster","1 Prospective cohort study Inclusion criteria Patients \\> 18 years of age who are to be immunized against HZ\n\nExclusion criteria:\n\n* Pregnant women\n* Patients with altered level of consciousness (dementia and others) who do not complete the questionnaires\n* Patients who do not wish to participate in the study 5.2 Retrospective cohort study Inclusion criteria Adults \\>18 years of age with a diagnosis of HZ in the CMBD from 2012 to 2023 at the Jiménez Díaz Foundation hospital. Since the international classification of diseases changed from ICD 9 to ICD 10 in 2106, the codes to be used for the inclusion of patients in the study are described below.\n\nICD 9 053 Herpes zoster\n\nIncludes:\n\n* Herpes zoster\n* Zone 053.0 With meningitis 053.1 With other central nervous system complications\n* 053.10 With unspecified nervous system complications\n* 053.11 Geniculate herpes zoster or Herpetic geniculate ganglionitis\n* 053.12 Postherpetic trigeminal neuralgia\n* 053.13 Postherpetic polyneuropathy\n* 053.14 Herpes zoster myelitis\n* 053.19 Other 053.2 With ophthalmic complications\n* 053.20 Herpes zoster dermatitis of eyelid or Herpes zoster ophthalmicus\n* 053.21 Herpes zoster keratoconjunctivitis\n* 053.22 Herpes zoster iridocyclitis zoster\n* 053.29 Other 053.7 With other specific complications\n* 053.71 Otitis externa due to herpes zoster\n* 053.79 Other 053.8 With unspecified complications 053.9 Herpes zoster without complication Herpes zoster NOS ICD 10 B02 Herpes zoster\n\nIncludes:\n\n* herpes\n* zona B02.0 Encephalitis due to herpes zoster Meningoencephalitis due to zoster B02.1 Meningitis due to herpes zoster B02.2 Herpes zoster with other nervous system involvement\n* B02.21 Postherpetic geniculate ganglionitis\n* B02.22 Postherpetic trigeminal neuralgia\n* B02.23 Postherpetic polyneuropathy\n* B.02.24 Myelitis Postherpetic myelitis\n* B02.29 Other postherpetic nervous system involvement\n* B02.3 Ocular herpes zoster\n* B02.30 Ocular herpes zoster, unspecified\n* B02.31 Herpes zoster conjunctivitis\n* B02.32 Herpes zoster iridocyclitis\n* B02.33 Herpes zoster keratitis\n* B02.34 Herpes zoster scleritis\n* B02.39 Other herpes zoster eye disease\n* B02.7 Disseminated herpes zoster\n* B02.8 Herpes zoster with other complications\n* B02.9 Uncomplicated herpes zoster\n* B02.39 Herpes zoster otitis externa NEOM\n\nExclusion criteria:\n\nPatients who are vaccinated against HZV","ALL","18 Years",{"count":43,"type":44},357,"ESTIMATED","OBSERVATIONAL","Title: Impact on quality of life and disease burden in adults with herpes zoster\n\nProspective cohort study for the primary objective and the secondary objectives (1 and 2) and retrospective cohort study for the secondary objective 3.\n\nDisease or disorder under study: Patients with a herpes zoster (HZ) diagnosis.",[48,49,50],"Herpes Zoster","Quality of Life","Immunization; Infection","NOT_YET_RECRUITING","2024-10-30",{"date":54,"type":55},"2024-10-31","ACTUAL",{"date":57,"type":44},"2024-11-04",{"date":59,"type":44},"2026-11-04",{"name":5,"class":6},1]